Pak Fah Yeow International Ltd
HKEX:239
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.13
2.64
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| HK |
|
Pak Fah Yeow International Ltd
HKEX:239
|
741.7m HKD |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD |
Loading...
|
|
| UK |
D
|
Dechra Pharmaceuticals PLC
F:1PK
|
5.1B EUR |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
529.7B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
275B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
210.9B GBP |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.8T DKK |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
221.6B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
269.1B USD |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
145.8B USD |
Loading...
|
Market Distribution
| Min | -36 930 000% |
| 30th Percentile | -5.1% |
| Median | 2.5% |
| 70th Percentile | 9.4% |
| Max | 8 238.3% |
Other Profitability Ratios
Pak Fah Yeow International Ltd
Glance View
Pak Fah Yeow International Ltd. is an investment holding company, which engages in the manufacture and sale of healthcare products under the brand name of Hoe Hin. The firm operates through three segments. Healthcare segment is engaged in the manufacture and sales of Hoe Hin products. Property Investment segment is engaged in the investment in commercial, industrial and residential properties. Treasury Investment segment is engaged in treasury investment. The firm mainly operates businesses in Hong Kong, China, Britain and Singapore, among others.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Pak Fah Yeow International Ltd is 49.4%, which is above its 3-year median of 49%.
Over the last 3 years, Pak Fah Yeow International Ltd’s Operating Margin has increased from 30.4% to 49.4%. During this period, it reached a low of 30.4% on May 30, 2022 and a high of 56.6% on Jun 30, 2024.